Cutler Group LLC / CA - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21
+50.0%
9,600
+357.1%
0.00%0.0%
Q2 2023$14
+16.7%
2,1000.0%0.00%
+100.0%
Q1 2023$12
-63.6%
2,100
-77.3%
0.00%
-66.7%
Q4 2022$33
-99.9%
9,231
-63.5%
0.00%
+200.0%
Q3 2022$27,000
-53.4%
25,300
-7.0%
0.00%
-75.0%
Q2 2022$58,000
-72.4%
27,200
-75.7%
0.00%
-63.6%
Q1 2022$210,000
-56.2%
112,014
+87.6%
0.01%
-45.0%
Q4 2021$480,000
-58.0%
59,703
-60.3%
0.02%
-60.8%
Q3 2021$1,142,000
+89.7%
150,226
+42.4%
0.05%
+82.1%
Q2 2021$602,000
+4530.8%
105,493
+282.2%
0.03%
+2700.0%
Q1 2021$13,000
-92.0%
27,600
-24.0%
0.00%
-87.5%
Q4 2020$163,000
-39.6%
36,300
+179.0%
0.01%
-52.9%
Q3 2020$270,000
+938.5%
13,009
-68.8%
0.02%
+750.0%
Q2 2020$26,000
-86.2%
41,700
-17.6%
0.00%
-80.0%
Q1 2020$189,000
+177.9%
50,600
+411.1%
0.01%
+150.0%
Q4 2019$68,000
+1033.3%
9,900
-33.6%
0.00%
+300.0%
Q3 2019$6,000
-53.8%
14,900
+186.5%
0.00%0.0%
Q2 2019$13,000
-78.3%
5,200
-65.3%
0.00%
-75.0%
Q3 2018$60,000
+39.5%
15,000
-1.9%
0.00%0.0%
Q1 2018$43,000
+186.7%
15,296
-12.1%
0.00%
Q4 2017$15,000
+66.7%
17,400
+295.5%
0.00%
Q3 2017$9,000
-82.0%
4,400
-86.8%
0.00%
-100.0%
Q2 2017$50,00033,4000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Perceptive Advisors 12,201,261$203,150,0004.07%
Paradigm Biocapital Advisors LP 907,428$15,109,0004.00%
Avoro Capital Advisors LLC 9,125,000$151,931,0002.77%
Logos Global Management LP 1,000,000$16,650,0002.16%
Avidity Partners Management LP 6,043,219$100,620,0002.10%
Orbimed Advisors 6,633,006$110,440,0001.79%
Parametrica Management Ltd 134,679$2,240,0001.66%
Boxer Capital, LLC 1,935,133$32,220,0001.66%
Fairmount Funds Management LLC 389,588$6,487,0001.53%
Long Focus Capital Management, LLC 705,000$11,738,0001.51%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders